Works matching IS 00071048 AND DT 2010 AND VI 151 AND IP 1


Results: 23
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.

    Published in:
    British Journal of Haematology, 2010, v. 151, n. 1, p. 47, doi. 10.1111/j.1365-2141.2010.08315.x
    By:
    • Romaguera, Jorge E.;
    • Fayad, Luis E.;
    • McLaughlin, Peter;
    • Pro, Barbara;
    • Rodriguez, Alma;
    • Wang, Michael;
    • Weaver, Pamela;
    • Hartig, Kimberly;
    • Kwak, Larry W.;
    • Feldman, Tatyana;
    • Smith, Judy;
    • Ford, Peggy;
    • Goldberg, Stuart;
    • Pecora, Andrew;
    • Goy, Andre
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Corrigendum.

    Published in:
    2010
    Publication type:
    Correction Notice
    22

    Corrigendum.

    Published in:
    2010
    Publication type:
    Correction Notice
    23